MHS Baldivis

MHS is the only metabolic health company vertically integrated from R&D and Manufacturing, through to the delivery of clinical services. This provides unique insights for both patients and providers and supports the provision of effective personalised metabolic health. METS_iQ™ delivers these insights at scale to meet the global health pandemic of obesity and weight related metabolic health disorders, particularly monitoring and supporting the new GLP-1 RA therapeutics and in bariatric care. Metabolic Health Solutions (MHS) is an award winning medical technology and digital health company, commercialising low cost, metabolic measurement technology and clinical decision support software. Poor metabolic health impacts directly on common chronic diseases such as obesity and diabetes. MHS is an ISO-13485 certified manufacturer with regulatory certification for its lead technology ECAL. In 2025, MHS will launch METS_iQ, a clinical digital metabolic platform, and now seek partners and investors to scale. MHS have helped more than 1000 West Australians improve their metabolic health since 2014. 96% of weight management clients successfully lose weight with us and 74% maintain weight loss over 12 months. Our clinically significant results are associated with a reduction in diabetes risk, pain and medication requirements. Many clients also report improved energy, sleep and overall wellbeing.